Ekkehard Brockstedt MSc, PhD, MBA

Ekkehard Brockstedt is a clinical research professional with more than 18 years of experience in drug development from phase II-IV with a focus on biologics. He has led the conduct of global clinical trial programmes in multiple therapeutic areas such as immunology/inflammatory diseases (Rheumatoid Arthritis, Crohn’s disease, Ulcerative Colitis, Psoriasis) and cardio-metabolic diseases (Stroke, DVT).

Prior to joining Boehringer Ingelheim he has held various project leader positions in clinical research and R&D project management at PRA Health Sciences Inc., Sankyo Pharma GmbH as well as Schering AG. Ekkehard holds an MSc in chemistry from the Freie University, Berlin, a PhD in biochemistry from the Technische University, Berlin (Max-Delbruck-Centrum für Molekulare Medizin Berlin) and an MBA from the University of Edinburgh.